Short answer · Medically reviewed summary · Last updated: 2026-05-08
TL;DR: Hypochondroplasia is a genetic condition caused by specific mutations in the FGFR3 gene, which disrupt normal bone growth by interfering with the conversion of cartilage to bone. It is inherited in an autosomal dominant pattern, meaning a single copy of the mutated gene from one parent is sufficient to cause the condition. What causes Hypochondroplasia? The primary cause of Hypochondroplasia is a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene.
TL;DR: Hypochondroplasia is a genetic condition caused by specific mutations in the FGFR3 gene, which disrupt normal bone growth by interfering with the conversion of cartilage to bone. It is inherited in an autosomal dominant pattern, meaning a single copy of the mutated gene from one parent is sufficient to cause the condition.
The primary cause of Hypochondroplasia is a mutation in the fibroblast growth factor receptor 3 (FGFR3) gene. This gene provides instructions for making a protein that plays a critical role in bone development. In individuals with Hypochondroplasia, the mutation causes the FGFR3 protein to be overactive, which inhibits the growth of chondrocytes (cartilage cells) in the growth plates of long bones. Think of this process like a "dimmer switch" that has been stuck in the "low" position, preventing bones from reaching their expected length during development.
Yes, Hypochondroplasia is inherited in an autosomal dominant pattern. This means that if one parent has the condition, there is a 50% chance they will pass the mutated FGFR3 gene to each child. However, it is important to note that many cases of Hypochondroplasia occur as a "de novo" or spontaneous mutation, meaning the mutation arises for the first time in the individual without a family history of the condition.
The genetic basis of Hypochondroplasia involves specific molecular changes, most commonly a point mutation known as c.1620C>A (p.Asn540Lys). Key genetic facts include:
While the role of the FGFR3 gene is well-established, researchers are still investigating why the clinical severity of Hypochondroplasia varies so significantly between individuals, even those with the exact same mutation. Current research is focused on how other genetic "background" factors influence the expression of the FGFR3 protein. Understanding these modifiers is a major goal for the 22 members of our DiseaseMaps community and the broader scientific field, as it may eventually lead to targeted therapeutic interventions.
Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.